Trials / Completed
CompletedNCT04005612
Effect of Vitamin d and Omega 3 on Osteocalcin
Assessing the Combined Effect of Omega-3 Fatty Acid and Vitamin D3 on Plasma Osteocalcin Levels : a Randomized Controlled Trial in Males and Females With Vitamin D Deficiency
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Applied Science Private University · Academic / Other
- Sex
- All
- Age
- 22 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Assessing the combined effect of omega-3 fatty acid and vitamin D 3 on plasma osteocalcin levels
Detailed description
The data about effect of vitamin D3 (VD3) and omega-3 fatty acids(omega-3FA) on plasma levels of osteocalcin (OCN) are scarce and conflicting and nothing is published in the literature about the effect of the combination of VD3 and omega-3FA on the OCN levels. This study was conducted to investigate effect of VD3 and omega-3FA alone and with each other on PLASMA OCN levels in females and males with vitamin D deficiency (VDD). This randomized, controlled clinical trial was designed to test effects of 50,000 IU VD3 weekly and 300 mg omega-3FA daily for eight weeks,separately and with each other, on the plasma levels of OCN and 25-hydroxy vitamin D (25OHD). This study was conducted during winter in 86 healthy Jordanian females and males with VDD with a mean age of (40± 10) years. Fasting serum levels for 25OHD,OCN, PTH (parathyroid hormone),calcium, phosphate, ALT (alanine aminotransferase), and urea were assessed at baseline and the end of the trial .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | vitamin D3 | 50,000 IU VD3 / week for 8 weeks |
| DIETARY_SUPPLEMENT | omega-3 fatty acid | 300 mg of omega 3-FA once daily for 8 weeks |
| DIETARY_SUPPLEMENT | vitamin D3 and omega-3 fatty acid | 50,000 IU VD3 / week for 8 weeks and 300 mg of omega-3FA once daily for 8 weeks |
| OTHER | control | no intervention |
Timeline
- Start date
- 2019-11-01
- Primary completion
- 2020-02-01
- Completion
- 2020-02-01
- First posted
- 2019-07-02
- Last updated
- 2020-07-14
Locations
1 site across 1 country: Jordan
Source: ClinicalTrials.gov record NCT04005612. Inclusion in this directory is not an endorsement.